Press Releases

THOUSAND OAKS, Calif., Nov. 21, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the successful completion of its acquisition of worldwide rights to Otezla® (apremilast), the only oral, non-biologic treatment for moderate-to-severe plaque psoriasis and psoriatic arthritis. Otezla was acquired from Celgene Corporation (NASDAQ:CELG) in connectio

MIAMI, Nov. 21, 2019 /PRNewswire/ -- Solis Health Plans hosted "Un Paseo Por La Salud," a health and wellness stroll for the South Flori

MINNEAPOLIS, Nov. 21, 2019 /PRNewswire/ -- Excelera®, the company behind the Excelera Network, a nationwide network of leading health systems and academic medical centers wit

WALTHAM, Mass., Nov. 21, 2019 /PRNewswire/ -- Boston IVF, the most experienced fertility provider in Massachusetts, offering world-renowned fertility treatment services, today announced it has opened the doors of its new Worcester Fertility Center. Located at 100 MLK Jr. Blvd., (Suite 300), Boston IVF's Worcester Fertility Center i

TARRYTOWN, N.Y., Nov. 21, 2019 /PRNewswire/ -- Araim Pharmaceuticals,  Inc. is pleased to announce the appointment of Ferdinand "Ferry" Breedveld, MD, PhD, th

HONG KONG, Nov. 20, 2019 /PRNewswire/ -- Cosmoprof Asia 2019, the leading B2B event for the beauty industry in the Asia-Pacific region, announced the winners of Cosmopack and Cosmoprof Asia Awards last night during the Awards Ceremony at the Hong Kong Convention and Exhibition Centre attended by some 300 guests.

SUZHOU, China and ROCKVILLE, Md., Nov. 20, 2019 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies, announced that the groundbreaking ceremony for the Company's global headquarters, R&D center, and manufacturing facility took place today at the Suz

TOKYO and COLUMBIA, Md., Nov. 20, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas" ) and Welldoc, Inc. (President, CEO: Kevin McRaith, "Welldoc") today announced that the companies have entered into a collaboration and license agreement direct

MINNEAPOLIS, Nov. 20, 2019 /PRNewswire/ -- OFT Food Safety & Injury Lawyers have been retained by multiple Wisconsin families in connection with a current E. coli

TEL AVIV, Israel, Nov. 20, 2019 /PRNewswire/ -- Therapix Biosciences Ltd. ("Therapix" or the "Company") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today that it received a written Notice of Delisting from the Listing Qualifications Department of The Nasdaq Capital Mar